Glial cell induced neural differentiation of bone marrow stromal cells
Background: Bone marrow stromal cells (BMSCs) have an necessary utility prospect within the area of cell remedy for varied neurodegenerative ailments, and inducing components that regulate BMSC differentiation are proposed as a promising therapeutic technique. On this examine, we explored the impact of glial cell-derived neurotrophic issue (GDNF) on the course of BMSC differentiation.
Strategies: BMSCs have been remoted from rat bone marrow and induced by GDNF. The results of GDNF on BMSC viability and proliferation have been verified by cell counting equipment-8, MTT, bromodeoxyuridine, and move cytometry assays. Neuronal differentiation from BMSCs was detected by quantitative real-time polymerase chain response and immunofluorescence through measuring the expression of a number of neural particular markers.
Outcomes: In comparison with untreated BMSCs, GDNF induced the differentiation of BMSCs into neuron-like cells and enhanced the expression ranges of neuronal markers together with nestin and NCAM. Furthermore, the expression of SCF was suppressed by GDNF stimulation.
Conclusion: GDNF may elevate the differentiation of BMSCs into neuron-like cells and may very well be thought-about as an efficient candidate cell for future neuroscience analysis.
Key phrases: Alzheimer’s illness; bone marrow stromal cells; cell remedy; glial cell-derived neurotrophic issue; neuronal differentiation.

Molecular detection of Mycobacterium tuberculosis from buccal swabs amongst grownup in Peru

Tuberculosis (TB) prognosis depends on a sputum pattern, which can’t be simply obtained from all symptomatic sufferers. Mycobacterium tuberculosis DNA will be detected from oral swabs, a noninvasive, protected different pattern sort; nonetheless, reported sensitivities have been variable and sure rely upon pattern assortment, processing procedures and host traits. We analyzed three buccal swab samples from 123 adults with culture-confirmed TB in Lima, Peru. We in contrast the sensitivity and specificity of two pattern assortment units (OmniSwab and EasiCollect FTA playing cards) and examined components related to detection. DNA was extracted with a commercially out there equipment and detected through real-time PCR IS6110 amplification.
General sensitivity for buccal samples was 51% (95% Confidence Interval [CI] 42-60%). Specificity from a single pattern amongst wholesome controls was 96.7% (95% CI 83-99.9%). Optimistic sputum smear and cavitary illness, correlates of illness burden, have been related to detection through buccal swab. Though we noticed greater sensitivities with the Omniswab samples, this gave the impression to be due primarily to variations in affected person traits (e.g., cavitary illness). General, our findings assist the potential for a buccal sample-based TB assay. Future work ought to concentrate on assay optimization and streamlining the assay workflow.
Our outcomes confirmed that SSa pretreatment may considerably scale back mind harm, enhance neurological operate restoration, and reduce the water content material of mind tissues in comparison with the mannequin group. SSa pretreatment considerably lowered the serum HMGB1 degree and downregulated the contents of inflammatory cytokines together with tumor necrosis factor-α, interleukin-1 beta, and interleukin-6. Moreover, SSa pretreatment may attenuate the decreased TLR4 and nucleus NF-κB within the mind of MCAO rats. The protein degree of HMGB1 within the nucleus was considerably upregulated within the SSa pretreatment group.
We ready CDDP/CQ-PLA NPs and CDDP-PLA NPs. Transmission electron microscope (TEM) and dynamic gentle scattering (DLS) have been used to detect the physiological traits and particle dimension parameters of drug-loaded nanoparticles. The drug focus and cumulative launch have been measured by UV and visual spectrophotometer. MTT assay was used to detect viability of Cal-27 cells. Annexin/PI staining was used to detect cell apoptosis. Organic kits have been used to detect malondialdehyde (MDA) content material, catalase (CAT) exercise, antioxidant enzyme superoxide dismutase (SOD) exercise and glutathione peroxidase (GSH PX) exercise in Cal-27 cells. Western blot was used to detect apoptosis and autophagy of Cal-27 cells.
 Glial cell induced neural differentiation of bone marrow stromal cells

Glial cell induced neural differentiation of bone marrow stromal cells

Salivary Carbohydrate-Poor Transferrin in Alcohol- and Nicotine-Dependent Males

Serum carbohydrate-deficient transferrin (CDT), an 80 kDa glycoprotein, is among the mostly employed biomarkers to detect alcohol dependence. Some salivary glycoproteins comparable to α-amylase, clusterin, haptoglobin, gentle/heavy-chain immunoglobulin, and transferrin, which alter glycosylation in alcohol-dependent individuals, have been recommended to be potential alcohol markers. Nevertheless, their identification is predicated on oblique evaluation of lectin glycosidic bonds and molecular weight. We investigated the CDT content material within the saliva of alcohol- and nicotine-dependent males.
The CDT focus (ng/mL, ng/mg protein) was decided by an Enzyme-Linked Immunosorbent Assay (ELISA) industrial equipment in 55 males: 20 wholesome social drinkers (C), 10 power cigarette people who smoke (S), 10 alcohol-dependent non-smokers (A), and 15 alcohol-dependent people who smoke (AS). Surprisingly, there have been no variations within the concentrations of CDT between the studied teams. Salivary pH was the bottom within the AS and the best within the A gaggle. Subsequently, salivary CDT can’t be used as an alcohol dependence marker as measured by ELISA. We recommend that direct identification of glycoproteins is important to seek for potential salivary alcohol biomarkers. Molecules smaller than 40 kDa, which simply translocate from blood to the saliva, could be most popular as salivary alcohol markers.

TAGAP Recombinant Protein (Human) (Recombinant- Tag)

RP030880 100 ug Ask for price

TAGLN Recombinant Protein (Human) (Recombinant- Tag)

RP030883 100 ug Ask for price

TAGLN Recombinant Protein (Human) (Recombinant- Tag)

RP030886 100 ug Ask for price

TAGAP Recombinant Protein (Human) (Recombinant- Tag)

RP043930 100 ug Ask for price

CTAGE5 Recombinant Protein (Mouse) (Recombinant- Tag)

RP126449 100 ug Ask for price

CTAGE5 Recombinant Protein (Mouse) (Recombinant- Tag)

RP126452 100 ug Ask for price

CTAGE5 Recombinant Protein (Mouse) (Recombinant- Tag)

RP126455 100 ug Ask for price

CTAGE1 Recombinant Protein (Human) (Recombinant- Tag)

RP008266 100 ug Ask for price

CTAGE5 Recombinant Protein (Human) (Recombinant- Tag)

RP008269 100 ug Ask for price

CTAGEP Recombinant Protein (Human) (Recombinant- Tag)

RP008275 100 ug Ask for price

Tagap1 Recombinant Protein (Mouse) (Recombinant Tag)

RP177158 100 ug Ask for price

TAGLN2 Recombinant Protein (Mouse) (Recombinant Tag)

RP177164 100 ug Ask for price

TAGLN3 Recombinant Protein (Mouse) (Recombinant Tag)

RP177167 100 ug Ask for price

TAGLN2 Recombinant Protein (Human) (Recombinant Tag)

RP030889 100 ug Ask for price

TAGLN2 Recombinant Protein (Human) (Recombinant Tag)

RP030892 100 ug Ask for price

TAGLN3 Recombinant Protein (Human) (Recombinant Tag)

RP030895 100 ug Ask for price

CTAGE4 Recombinant Protein (Human) (Recombinant- Tag)

RP053403 100 ug Ask for price

CTAGE8 Recombinant Protein (Human) (Recombinant- Tag)

RP053409 100 ug Ask for price

CTAGE9 Recombinant Protein (Human) (Recombinant- Tag)

RP053412 100 ug Ask for price

CTAG1A Recombinant Protein (Human) (Recombinant- Tag)

RP038332 100 ug Ask for price

CTAG1B Recombinant Protein (Human) (Recombinant- Tag)

RP038335 100 ug Ask for price

CTAGE5 Recombinant Protein (Human) (Recombinant- Tag)

RP038338 100 ug Ask for price

Glyco Recombinant Protein A33 Recombinant Protein

96-361 0.05 mg
EUR 619.8
Description: Glycoprotein A33 (GPA33) is also known as Cell surface A33 antigen, is a single-pass type I membrane protein which is expressed in normal gastrointestinal epithelium and in 95% of colon cancers. GPA33 The predicted mature protein has a 213-amino acid extracellular region, a single transmembrane domain, and a 62-amino acid intracellular tail. The sequence of the extracellular region contains 1 Ig-like C2-type (immunoglobulin-like) domain and 1 Ig-like V-type (immunoglobulin-like) domain characteristic of the CD2 subgroup of the immunoglobulin (Ig) superfamily, which contains. GPA33 may play a role in cell-cell recognition and signaling.

Glyco Recombinant Protein A33 Recombinant Protein

96-364 0.05 mg
EUR 619.8
Description: Glycoprotein A33 (GPA33) is also known as Cell surface A33 antigen, is a single-pass type I membrane protein which is expressed in normal gastrointestinal epithelium and in 95% of colon cancers. GPA33 The predicted mature protein has a 213-amino acid extracellular region, a single transmembrane domain, and a 62-amino acid intracellular tail. The sequence of the extracellular region contains 1 Ig-like C2-type (immunoglobulin-like) domain and 1 Ig-like V-type (immunoglobulin-like) domain characteristic of the CD2 subgroup of the immunoglobulin (Ig) superfamily, which contains. GPA33 may play a role in cell-cell recognition and signaling.

CTAGE6P Recombinant Protein (Human) (Recombinant Tag)

RP008272 100 ug Ask for price

STAG3L1 Recombinant Protein (Human) (Recombinant Tag)

RP030283 100 ug Ask for price

STAG3L2 Recombinant Protein (Human) (Recombinant Tag)

RP030286 100 ug Ask for price

STAG3L3 Recombinant Protein (Human) (Recombinant Tag)

RP030289 100 ug Ask for price

STAG3L4 Recombinant Protein (Human) (Recombinant Tag)

RP030292 100 ug Ask for price

CTAGE3P Recombinant Protein (Human) (Recombinant Tag)

RP053400 100 ug Ask for price

CTAG2 Recombinant Protein (Rat) (Recombinant-P Tag)

RP196619 100 ug Ask for price

CTAG2 Recombinant Protein (Mouse) (Recombinant-P Tag)

RP126446 100 ug Ask for price

CTAG2 Recombinant Protein (Human) (Recombinant-P Tag)

RP053376 100 ug Ask for price

TWEAK, recombinant / TNFSF12, recombinant (Human) - ELISA Kit

EK-054-85 96 wells
EUR 660.96

Mouse Recombinant anti-Rat CD3 Recombinant Antibody

xAP-0878 100ug
EUR 280

Rat Recombinant anti-Mouse CD25 Recombinant Antibody

xAP-0593 100ug
EUR 280

Rat Recombinant anti-Mouse CD31 Recombinant Antibody

xAP-0619 100ug
EUR 280

Rat Recombinant anti-Mouse CD45.1 Recombinant Antibody

xAP-0659 100ug
EUR 280

Rat Recombinant anti-Mouse CD45.2 Recombinant Antibody

xAP-0661 100ug
EUR 280

Rat Recombinant anti-Mouse CD69 Recombinant Antibody

xAP-0686 100ug
EUR 280

Rat Recombinant anti-Mouse CD73 Recombinant Antibody

xAP-0689 100ug
EUR 280

Recombinant HIV Recombinant HIV gp120 Protein (His Tag)

PKSQ050061-10ug 10ug
EUR 49
Description: HIV

Recombinant HIV Recombinant HIV gp120 Protein (His Tag)

PKSQ050061-50ug 50ug
EUR 148
Description: HIV

Mouse Recombinant anti-Human CD4 Recombinant Antibody

xAP-0266 100ug
EUR 280

Mouse Recombinant anti-Human CD8 Recombinant Antibody

xAP-0344 100ug
EUR 280

Mouse Recombinant anti-Human LAP Recombinant Antibody

xAP-0443 100ug
EUR 280

Rat Recombinant anti-Mouse CD11c Recombinant Antibody

xAP-0518 100ug
EUR 280

Rat Recombinant anti-Mouse CD154 Recombinant Antibody

xAP-0545 100ug
EUR 280

Rat Recombinant anti-Mouse CD62L Recombinant Antibody

xAP-0679 100ug
EUR 280

Mouse Recombinant anti-Rat CD161 Recombinant Antibody

xAP-0871 100ug
EUR 280

Human sCD42b/GP1Ba , recombinant Human Recombinant Protein

S01-084 50 µg
EUR 196.35
Description: CD42b, also known as GP1Ba (GP1B alpha, Glycoprotein 1Ba) is a single pass transmembrane glycoprotein that functions as the key ligand binding subunit of the GP1B platelet surface receptor. The association of CD42b/GP1Ba with GP1Bb (covalently) and platelet glycoproteins IX and V (non‐covalently) forms the von Willebrand factor receptor. The binding of von Willebrand factor (VWF) to its platelet receptor initiates the primary mechanism for the adhesion of platelets to a site of vascular injury and subsequent platelet activation. Additionally, the cytoplasmic (C‐terminal) domain of CD42b/GP1Ba can bind and activate signal transduction molecules, including 14‐3‐3ζ and β‐filamin. Mutations in von Willebrand factor and to a lesser extent, CD42b/GP1Ba, that affect the binding of VWF to the GP1B receptor are the primary cause of the hereditary bleeding disorder known as Type 2 von Willebrand disease (VWD). Mutations in the CD42b/GP1Ba gene have also been linked to a related bleeding disorder, Bernard‐Soulier disease. Recombinant Human sCD42b/GP1Ba is a 54.6 kDa protein containing 496 amino acid residues that correspond to the extracellular portion of CD42b/GP1Ba, plus a C‐terminal His‐Tag. Due to glycosylation, it migrates at approximately 100‐115 kDa by SDS‐PAGE analysis under reducing and non‐reducing conditions.

Human sCD42b/GP1Ba , recombinant Human Recombinant Protein

S01-084S 10 µg
EUR 92.4
Description: CD42b, also known as GP1Ba (GP1B alpha, Glycoprotein 1Ba) is a single pass transmembrane glycoprotein that functions as the key ligand binding subunit of the GP1B platelet surface receptor. The association of CD42b/GP1Ba with GP1Bb (covalently) and platelet glycoproteins IX and V (non‐covalently) forms the von Willebrand factor receptor. The binding of von Willebrand factor (VWF) to its platelet receptor initiates the primary mechanism for the adhesion of platelets to a site of vascular injury and subsequent platelet activation. Additionally, the cytoplasmic (C‐terminal) domain of CD42b/GP1Ba can bind and activate signal transduction molecules, including 14‐3‐3ζ and β‐filamin. Mutations in von Willebrand factor and to a lesser extent, CD42b/GP1Ba, that affect the binding of VWF to the GP1B receptor are the primary cause of the hereditary bleeding disorder known as Type 2 von Willebrand disease (VWD). Mutations in the CD42b/GP1Ba gene have also been linked to a related bleeding disorder, Bernard‐Soulier disease. Recombinant Human sCD42b/GP1Ba is a 54.6 kDa protein containing 496 amino acid residues that correspond to the extracellular portion of CD42b/GP1Ba, plus a C‐terminal His‐Tag. Due to glycosylation, it migrates at approximately 100‐115 kDa by SDS‐PAGE analysis under reducing and non‐reducing conditions.

Mouse Recombinant anti-Human CD10 Recombinant Antibody

xAP-0047 100ug
EUR 280

Mouse Recombinant anti-Human CD14 Recombinant Antibody

xAP-0102 100ug
EUR 280

Mouse Recombinant anti-Human CD14 Recombinant Antibody

xAP-0103 100ug
EUR 280

Mouse Recombinant anti-Human CD14 Recombinant Antibody

xAP-0104 100ug
EUR 280

Mouse Recombinant anti-Human CD15 Recombinant Antibody

xAP-0118 100ug
EUR 280

Mouse Recombinant anti-Human CD16 Recombinant Antibody

xAP-0129 100ug
EUR 280

Mouse Recombinant anti-Human CD25 Recombinant Antibody

xAP-0197 100ug
EUR 280

Mouse Recombinant anti-Human CD27 Recombinant Antibody

xAP-0204 100ug
EUR 280

Mouse Recombinant anti-Human CD38 Recombinant Antibody

xAP-0258 100ug
EUR 280

Mouse Recombinant anti-Human CD38 Recombinant Antibody

xAP-0259 100ug
EUR 280

Mouse Recombinant anti-Human CD40 Recombinant Antibody

xAP-0269 100ug
EUR 280

Mouse Recombinant anti-Human CD45 Recombinant Antibody

xAP-0280 100ug
EUR 280

Mouse Recombinant anti-Human CD45 Recombinant Antibody

xAP-0281 100ug
EUR 280

Mouse Recombinant anti-Human CD52 Recombinant Antibody

xAP-0300 100ug
EUR 280

Mouse Recombinant anti-Human CD53 Recombinant Antibody

xAP-0301 100ug
EUR 280

Mouse Recombinant anti-Human CD57 Recombinant Antibody

xAP-0311 100ug
EUR 280

Mouse Recombinant anti-Human CD59 Recombinant Antibody

xAP-0314 100ug
EUR 280

Mouse Recombinant anti-Human CD80 Recombinant Antibody

xAP-0347 100ug
EUR 280

Mouse Recombinant anti-Human CD8a Recombinant Antibody

xAP-0360 100ug
EUR 280

Mouse Recombinant anti-Human CD8b Recombinant Antibody

xAP-0361 100ug
EUR 280

Mouse Recombinant anti-Mouse CD19 Recombinant Antibody

xAP-0562 100ug
EUR 280

Mouse Recombinant anti-Mouse CD20 Recombinant Antibody

xAP-0570 100ug
EUR 280

Mouse Recombinant anti-Mouse CD3e Recombinant Antibody

xAP-0641 100ug
EUR 280

Mouse Recombinant anti-Mouse CD45 Recombinant Antibody

xAP-0657 100ug
EUR 280

Mouse Recombinant anti-Mouse CD48 Recombinant Antibody

xAP-0666 100ug
EUR 280

Mouse Recombinant anti-Mouse CD8a Recombinant Antibody

xAP-0705 100ug
EUR 280

Mouse Recombinant anti-Human CD11b Recombinant Antibody

xAP-0072 100ug
EUR 280

Mouse Recombinant anti-Human CD123 Recombinant Antibody

xAP-0081 100ug
EUR 280

Mouse Recombinant anti-Human CD161 Recombinant Antibody

xAP-0132 100ug
EUR 280

Mouse Recombinant anti-Human CD163 Recombinant Antibody

xAP-0136 100ug
EUR 280

Mouse Recombinant anti-Human CD305 Recombinant Antibody

xAP-0225 100ug
EUR 280

Mouse Recombinant anti-Human CD62L Recombinant Antibody

xAP-0319 100ug
EUR 280

Mouse Recombinant anti-Human CD66b Recombinant Antibody

xAP-0328 100ug
EUR 280

Mouse Recombinant anti-Mouse CD103 Recombinant Antibody

xAP-0499 100ug
EUR 280

Rat Recombinant anti-Mouse NK-1.1 Recombinant Antibody

xAP-0801 100ug
EUR 280

Recombinant Rat Apoliprotein-J (Clusterin Rat Recombinant)

CC015-002 2ug
EUR 351.6

Recombinant Rat Apoliprotein-J (Clusterin Rat Recombinant)

CC015-010 10ug
EUR 489.6

Recombinant Rat Apoliprotein-J (Clusterin Rat Recombinant)

CC015-101 1mg
EUR 8322

Mouse Recombinant anti-Human CD45RA Recombinant Antibody

xAP-0283 100ug
EUR 280

Mouse Recombinant anti-Human CD45RB Recombinant Antibody

xAP-0285 100ug
EUR 280

Recombinant SARS-CoV Spike S2-His Recombinant Protein

PKSV030250-100ug 100ug
EUR 1105
Description: SARS

Mouse Recombinant anti-Mouse F4/80 Recombinant Antibody

xAP-0720 100ug
EUR 280

Rat Recombinant anti-Mouse Ki-67 Recombinant Antibody

xAP-0775 100ug
EUR 280

Mouse Recombinant anti-Mouse TCR ¿/d Recombinant Antibody

xAP-0825 100ug
EUR 280

Rat Recombinant anti-Mouse/Rat XCR1 Recombinant Antibody

xAP-0858 100ug
EUR 280

Thyroid Stimulating Hormone (TSH) Recombinant (Human recombinant)

GWB-9ADB0F 0.1 mg Ask for price

Rat Recombinant anti-Mouse Podoplanin Recombinant Antibody

xAP-0813 100ug
EUR 280

HSA Recombinant, Human Serum Albumin Recombinant Protein, HEK

PROTP02768-2 Regular: 100ug
EUR 380.4
Description: Recombinant Human Serum Albumin produced in HEK cells is a glycosylated monomer, having a molecular weight range of 60-65kDa due to glycosylation.;The HSA is purified by proprietary chromatographic techniques.

Rat Recombinant anti-Mouse CD206 (MMR) Recombinant Antibody

xAP-0578 100ug
EUR 280

Mouse Recombinant anti-Mouse H-2Kd Recombinant Antibody

xAP-0736 100ug
EUR 280

Rat Recombinant anti-Mouse CD192 (CCR2) Recombinant Antibody

xAP-0001 100ug
EUR 280

Mouse Recombinant anti-Human CD95 (Fas) Recombinant Antibody

xAP-0367 100ug
EUR 280

Mouse Recombinant anti-Human HLA-DR Recombinant Antibody

xAP-0387 100ug
EUR 280

Rat Recombinant anti-Mouse CD192 (CCR2) Recombinant Antibody

xAP-0564 100ug
EUR 280

Rat Recombinant anti-Mouse/Human CD44 Recombinant Antibody

xAP-0842 100ug
EUR 280

Recombinant phosphopantetheine adenylyltransferase (PPAT) (Recombinant)

20-abx072018
  • Ask for price
  • Ask for price
  • Ask for price
  • 1 mg
  • 300 µg
  • 50 ug

Recombinant Human Apoliprotein-J (Clusterin Human Recombinant)

CC014-002 2ug
EUR 351.6

Recombinant Human Apoliprotein-J (Clusterin Human Recombinant)

CC014-010 10ug
EUR 489.6

Recombinant Human Apoliprotein-J (Clusterin Human Recombinant)

CC014-101 1mg
EUR 13344

Recombinant 5T4

RPU54319-100ug 100ug
EUR 591.8

Recombinant 5T4

RPU54319-1mg 1mg
EUR 2620.8

Recombinant 5T4

RPU53907-100ug 100ug
EUR 566.5

Recombinant 5T4

RPU53907-1mg 1mg
EUR 2511.6

Recombinant 5T4

RPU53907-50ug 50ug
EUR 455.4

Recombinant 5T4

RPU54319-50ug 50ug
EUR 475.2

Recombinant RFP

STA-202 100 ?g
EUR 470.4
Description:
  • Recombinant RFP contains a 6x-His tag at the C-terminus. Provided as 100 µg/vial at a concentration of 1 mg/mL.
  • Includes 6xHis-tag at C-terminus
  • Provided at 100 ?g/vial at 1.0 mg/mL in 1X PBS
  • Recombinant Protein purified from E. coli

Recombinant RFP

STA-202-5 5 x 100 µg
EUR 1681.2
Description:
  • Recombinant RFP contains a 6x-His tag at the C-terminus. Provided as 5 vials of 100 µg at a concentration of 1 mg/mL.
  • Includes 6xHis-tag at C-terminus
  • Provided at 100 ?g/vial at 1.0 mg/mL in 1X PBS
  • Recombinant Protein purified from E. coli

Recombinant 5T4

RPA434Hu01 10ug
EUR 184

Recombinant 5T4

RPA434Mu01 10ug
EUR 192

HSA Recombinant, Human Serum Albumin Recombinant Protein, Plant

PROTP02768-1 Regular: 50mg
EUR 565.2
Description: HSA Human Recombinant produced in Plant is a non-glycosylated, polypeptide chain containing 585 amino acids and having a molecular mass of 67 kDa.The optimum concentration for recombinant Albumin to be used in cell culture ranges between 0.5gr to 2gr per liter3.;The recombinant Albumin is purified by proprietary chromatographic techniques.

Mouse Recombinant anti-Human CD56 (NCAM) Recombinant Antibody

xAP-0308 100ug
EUR 280

Mouse Recombinant anti-Human CD56 (NCAM) Recombinant Antibody

xAP-0309 100ug
EUR 280

Rat Recombinant anti-Mouse/Human CD11b Recombinant Antibody

xAP-0840 100ug
EUR 280

Recombinant other HSA Recombinant Protein, Untagged, Rice-10mg

QP12317-10mg 10mg
EUR 195.6

Recombinant other HSA Recombinant Protein, Untagged, Rice-20ug

QP12317-20ug 20ug
EUR 186

Recombinant other HSA Recombinant Protein, Untagged, Rice-50mg

QP12317-50mg 50mg
EUR 435.6

sCD4 (Recombinant)

GWB-190669 0.1 mg Ask for price

TDO2 (Recombinant)

20-abx073952
  • Ask for price
  • Ask for price
  • Ask for price
  • 1 µg
  • 50 ug
  • 5 ug

YOD1 (Recombinant)

20-abx073982
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 10 ug
  • 2 µg

NAT6 (Recombinant)

20-abx073034
  • Ask for price
  • Ask for price
  • Ask for price
  • 10 ug
  • 2 µg
  • 5 ug

GALE (Recombinant)

20-abx073137
  • Ask for price
  • Ask for price
  • Ask for price
  • 1 mg
  • 25 ug
  • 5 ug

ADSL (Recombinant)

20-abx073250
  • Ask for price
  • Ask for price
  • Ask for price
  • 1 mg
  • 20 ug
  • 5 ug

MPST (Recombinant)

20-abx073378
  • Ask for price
  • Ask for price
  • Ask for price
  • 1 mg
  • 20 ug
  • 5 ug

TDP1 (Recombinant)

20-abx073385
  • Ask for price
  • Ask for price
  • Ask for price
  • 1 mg
  • 20 ug
  • 5 ug

MMP1 (Recombinant)

20-abx073422
  • Ask for price
  • Ask for price
  • Ask for price
  • 1 mg
  • 20 ug
  • 5 ug

ADAL (Recombinant)

20-abx073435
  • Ask for price
  • Ask for price
  • Ask for price
  • 1 mg
  • 20 ug
  • 5 ug

ACY1 (Recombinant)

20-abx073654
  • Ask for price
  • Ask for price
  • Ask for price
  • 10 ug
  • 1 mg
  • 2 µg

Recombinant EGFP

STA-201 100 ?g
EUR 300

Recombinant EGFP

STA-201-5 5 x 100 µg
EUR 1195

Recombinant B18R

inh-b18r 25 µg
EUR 259.35

Recombinant B18R

inh-b18r-20 500 µg
EUR 3322.2

Recombinant B18R

inh-b18r-5 5 x 25 µg
EUR 1038.45

Recombinant ZnT8

DAG-WT1343 1 mg
EUR 1460
Description: Recombinant

Recombinant other HSA Recombinant Protein, Untagged, Rice-100mg

QP12317-100mg 100mg
EUR 675.6

Mouse Recombinant anti-Human CD184 (CXCR4) Recombinant Antibody

xAP-0151 100ug
EUR 280

Mouse Recombinant anti-Mouse CD335 (NKp46) Recombinant Antibody

xAP-0628 100ug
EUR 280

Recombinant other HSA Recombinant Protein, Untagged, HEK 293-100ug

QP12317-100ug 100ug
EUR 241.2

Recombinant other HSA Recombinant Protein, Untagged, HEK 293-2mg

QP12317-2mg 2mg
EUR 1513.2

Rat Recombinant anti-Mouse TCR ß chain Recombinant Antibody

xAP-0822 100ug
EUR 280

Rat Recombinant anti-Mouse CD117 (c-kit) Recombinant Antibody

xAP-0511 100ug
EUR 280

ADAT1 (Recombinant)

20-abx073911
  • Ask for price
  • Ask for price
  • Ask for price
  • 10 ug
  • 1 mg
  • 2 µg
 KCNMB2-AS1 expression in NSCLC tissues and cells was detected utilizing reverse transcription-quantitative polymerase chain response. Cell proliferation, apoptosis, migration, and invasion have been evaluated utilizing Cell Counting Package-8, move cytometry, Transwell migration, and Transwell invasion assays, respectively. In vivo tumor xenograft fashions have been constructed to evaluate tumorigenicity. Bioinformatics predictions have been carried out to determine microRNAs concentrating on KCNMB2-AS1. Interactions between KCNMB2-AS1 and miR-374a-3p have been analyzed utilizing RNA immunoprecipitation, luciferase reporter, and rescue experiments.